NAMs Opportunity MB Research Laboratories emphasizes development and application of New Approach Methodologies (NAMs) and non-animal assays. This positions them to engage clients seeking modern, ethically aligned toxicology testing solutions and regulatory-ready data, including pharmaceutical, medical device, and chemical companies pursuing alternative testing strategies.

Regulatory Expertise With GLP compliance and experience across OECD, ISO 10993, and US EPA OCSPP guidelines, MB Research can target clients needing compliant safety studies for regulatory submissions, especially medical devices and complex chemical products, offering a one-stop provider for pan-regulatory needs.

Global Reach Operating since 1972 and serving industry and government clients worldwide, MB Research can pursue expansion into regions with strict toxicology requirements or growing regulatory demands, leveraging its long-standing reputation to win multinational contracts.

In Vitro Focus Core capabilities in skin and eye irritation, sensitization, cytotoxicity, and biocompatibility align with industries seeking faster, more ethical screening. This enables the company to upsell to clients adopting early-stage NAMs and high-throughput safety assessments.

Growth Levers Revenue in the lower-mid range and a lean team size indicate potential for scalable service expansion, such as adding remote or virtual study management, expanding NAM portfolios, or pursuing partnerships with larger CROs for larger, funded projects while maintaining regulatory credibility.